XOMA ROYALTY CORPORATION (XOMA:NASDAQ)
$41.7 0.05 (0.12%)
Analysed XOMA ROYALTY CORPORATION (XOMA:NASDAQ) News Sources
XOMA Royalty Q4 Earnings Call Highlights
18-03-2026
marketbeat.com
We Believe XOMA Royalty's (NASDAQ:XOMA) Earnings Are A Poor Guide For Its Profitability
26-03-2026
yahoo.com
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
27-04-2026
yahoo.com
Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal
27-04-2026
yahoo.com
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?
28-04-2026
yahoo.com
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates
06-05-2026
yahoo.com
Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates
08-05-2026
yahoo.com
Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates
11-05-2026
yahoo.com
Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates
15-05-2026
yahoo.com
What is the current price of XOMA ROYALTY CORPORATION (XOMA:NASDAQ)?
The current price of XOMA ROYALTY CORPORATION (XOMA:NASDAQ) is $41.7.
XOMA ROYALTY CORPORATION (XOMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of XOMA ROYALTY CORPORATION (XOMA:NASDAQ) since the previous trading day is $0.05.
XOMA ROYALTY CORPORATION (XOMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of XOMA ROYALTY CORPORATION (XOMA:NASDAQ) since the previous trading day is 0.12%.
What is the most recent average sentiment score for XOMA ROYALTY CORPORATION (XOMA:NASDAQ)?
The most recent average sentiment score for XOMA ROYALTY CORPORATION (XOMA:NASDAQ) is 39 out of 100.
What is the most recent average sentiment for XOMA ROYALTY CORPORATION (XOMA:NASDAQ)?
The most recent sentiment for XOMA ROYALTY CORPORATION (XOMA:NASDAQ) is .
SEC-8K** Filing Available For XOMA ROYALTY CORPORATION (XOMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.